Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SBBP

Strongbridge Biopharma

$7.60

-0.25 (-3.18%)

07:39
05/10/18
05/10
07:39
05/10/18
07:39
Earnings
Breaking Earnings news story on Strongbridge Biopharma »

Strongbridge increases…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

SBBP

Strongbridge Biopharma

$7.60

-0.25 (-3.18%)

07:38
05/10/18
05/10
07:38
05/10/18
07:38
Earnings
Strongbridge sees sufficient capital to achieve consistent positive cash flow »

Strongbridge had $92.4M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

SBBP

Strongbridge Biopharma

$7.60

-0.25 (-3.18%)

07:36
05/10/18
05/10
07:36
05/10/18
07:36
Earnings
Strongbridge Biopharma reports Q1 EPS (33c), consensus (40c) »

Reports Q1 revenue $3.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

Over a month ago
SBBP

Strongbridge Biopharma

$8.30

-0.2 (-2.35%)

17:48
04/05/18
04/05
17:48
04/05/18
17:48
Earnings
Strongbridge Biopharma sees FY18 revenue $16M-$19M, consensus $17.75M »

Guidance from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.50

(0.00%)

07:55
04/05/18
04/05
07:55
04/05/18
07:55
Conference/Events
Strongbridge Biopharma to host investor and analyst day »

Investor and Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.50

(0.00%)

04:55
04/05/18
04/05
04:55
04/05/18
04:55
Conference/Events
Strongbridge Biopharma to host investor and analyst day »

Investor and Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.85

0.2 (2.31%)

07:31
04/02/18
04/02
07:31
04/02/18
07:31
Hot Stocks
Strongbridge Biopharma announces dosing of first 4 patients in LOGICS study »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.85

0.2 (2.31%)

15:24
03/30/18
03/30
15:24
03/30/18
15:24
Conference/Events
Strongbridge Biopharma to host investor and analyst day »

Investor and Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.15

0.05 (0.62%)

16:18
03/20/18
03/20
16:18
03/20/18
16:18
Hot Stocks
Strongbridge Biopharma get patent for methods of treating Cushing's syndrome »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 05

    Apr

SBBP

Strongbridge Biopharma

$8.00

0.2 (2.56%)

14:50
03/18/18
03/18
14:50
03/18/18
14:50
Hot Stocks
Strongbridge Biopharma presents new data from in vitro study of levoketoconazole »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 05

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.